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Results: Data of measured depth activity distributions were 
prepared using the measured depth activity data. Activity 
pencil beam kernels needed for the APB algorithm were 
constructed using the data of measured depth activity 
distributions and calculations in lateral direction. Gaussian 
form was used for the lateral distribution data to take the 
effect of multiple Coulomb scattering into consideration. 
 
Conclusion: A method of obtaining the depth activity 
distributions and the APB algorithm were developed. The 
simulation system with the APB algorithm can be used in 
clinical proton therapy. 
 
OC-0456  
Translation of a prompt gamma based proton range 
verification system to first clinical application 
C. Richter
1OncoRay - National Center for Radiation Research in 
Oncology, Faculty of Medicine and University Hospital Carl 
Gustav Carus- Technische Universität Dresden- Helmholtz-
Zentrum Dresden-Rossendorf, Dresden, Germany 
1,2,3,4, G. Pausch1, S. Barczyk1,2, M. Priegnitz5, C. 
Golnik1, L. Bombelli6, W. Enghardt1,2,3,4, F. Fiedler5, C. 
Fiorini7, L. Hotoiu8, G. Janssens8, I. Keitz1, S. Mein1, I. Perali7, 
D. Prieels8, J. Smeets8, J. Thiele2, F. Vander Stappen8, T. 
Werner1, M. Baumann1,2,3,4 
2University Hospital Carl Gustav Carus- Technische 
Universität Dresden, Department of Radiation Oncology, 
Dresden, Germany 
3Helmholtz-Zentrum Dresden – Rossendorf, Institute of 
Radiooncology, Dresden, Germany 
4German Cancer Consortium DKTK and German Cancer 
Research Center DKFZ, Dresden, Germany 
5Helmholtz-Zentrum Dresden – Rossendorf, Institute of 
Radiation Physics, Dresden, Germany 
6XGLAB S.R.L, Milano, Italy 
7Politecnico di Milano, Dipartimento di Elettronica- 
Informazione e Bioingegneria, Milano, Italy 
8Ion Beam Applications SA, Louvain-la-Neuve, Belgium 
 
Purpose or Objective: To improve precision of particle 
therapy, in vivo range verification is highly desirable. 
Methods based on prompt gamma rays emitted during 
treatment seem promising but have not yet been applied 
clinically. Here we report on the translational 
implementation as well as the worldwide first clinical 
application of prompt gamma imaging (PGI) based range 
verification. 
 
Material and Methods: Focused on the goal of translating a 
knife-edge shaped slit camera prototype into clinical 
operation, we first systematically addressed remaining 
challenges and questions. A robust energy calibration routine 
and corresponding quality assurance protocols were 
developed. Furthermore, the positioning accuracy of the 
system was determined. The slit camera, intentionally 
developed for pencil beam scanning, was applied for double 
scattered (DS) proton beams. Systematic phantom 
experiments with increasing complexity have been 
performed.  
In the next step, the knife-edge shaped slit camera was 
applied clinically to measure the spatial prompt gamma ray 
distribution during a proton treatment of a head and neck 
tumor for seven consecutive fractions. Inter-fractional 
variations of the prompt gamma profile were evaluated. For 
three fractions in-room control CTs were acquired and 
evaluated for dose relevant changes. 
 
Results: In translational phantom experiments it was shown 
that proton range shifts can be visualized with the camera 
system for DS proton irradiation, proving its applicability 
under conditions of increased neutron background. Moreover, 
prompt gamma profiles for single iso-energy layers were 
extracted by synchronizing time resolved measurements to 
the rotation of the range modulator wheel of the DS 
treatment system. Furthermore, the position precision of the 
slit camera has been determined to provisionally be 1.1 mm 
(2σ).  
With this preparatory work, the first clinical application of 
the PGI slit camera was successful. Based on the PGI 
information, inter-fractional global range variations were in 
the range of ±2 mm for all evaluated fractions. The results of 
the iso-energy layer resolved prompt gamma profile analysis 
were in consistence with the sum profile analysis. Also the 
control CT based dose reconstruction revealed negligible 
range variations of about 1.5 mm. No influence of DVH 
parameters for target volume and organs at risk was found. 
 
 
 
Conclusion: This work demonstrates for the first time that 
prompt gamma ray based range verification can be applied 
for clinical treatment of patients. Further plans include the 
continuation of the clinical study to perform systematic 
evaluations based on an appropriate patient number. With 
the translation from basic physics experiments into clinical 
operation, the authors are confident that a prompt-gamma 
ray based technology is capable of range verification and can 
be used in the near future for online quality assurance as 
well as in midterm for potential margin reduction. 
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Purpose or Objective: The importance of MRI steadily 
increases in radiation oncology not only as multimodality 
imaging device but also as an implemented online imaging 
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technology. Imaging using MRI shows advantages compared to 
CT or CBCT offering superior soft tissue contrast without 
additional dose. Also in particle beam therapy integrated MR 
guided treatment units have great potential. A complete 
understanding of the particle beam characteristics in the 
presence of magnetic fields is required. So far, studies in this 
area are limited. 
 
Material and Methods: Protons (60-250MeV) and carbon ions 
(120-400MeV/u) in the clinically required energy range 
impinging on a phantom of 35x35x50cm³ size were simulated 
using the MC framework GATE 7. Homogeneous magnetic 
fields of 0.35T, 1T and 3T perpendicular to the initial beam 
axis were applied. The beam deflection, shape, and the 
energy spectrum at the Bragg peak area was analyzed. A 
numerical algorithm was developed for deflection curve 
generation solving the relativistic equations of motion taking 
into account the Lorentz force and particle energy loss. 
Additionally, dose variations on material boundaries induced 
by magnetic fields were investigated for 250MeV protons. 
 
Results: Transverse deflections up to 99mm were observed 
for 250MeV protons at 3T. Deflections for lower field 
strengths (e.g. future hybrid open-MRI proton delivery 
systems) yielded 12mm for 0.35T and 34mm for 1T. A change 
in the dose distribution at the Bragg-peak region was 
observed for protons. Energy spectrum analysis showed an 
asymmetric lateral energy distribution. The different particle 
ranges resulted in a tilted dose distribution, see Fig.1.The 
numerical algorithm successfully modeled the deflection 
curve, with a maximum deviation of 1.8% and calculation 
times of less than 5ms. For a 250MeV proton beam passing in 
a 3T field through multiple slabs (water-air-water), only a 4% 
local dose increase at the first boundary was observed in 
single voxels due to the electron return effect. 
 
Fig1: Deformed 2D dose distribution at the Bragg peak area 
for a 250MeV proton beam in a 3T field 
 
Conclusion: Beam deflections in magnetic fields could be 
described by a numerical algorithm. The observed change in 
dose distribution in the Bragg-peak region has to be taken 
into account in future dose calculations. However, local dose 
changes due to boundary effects seem to be negligible for 
clinical applications. Current work in progress deals with the 
inclusion of magnetic field effects in a dose calculation 
algorithm for particles. 
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Purpose or Objective: To test the ability of detecting small 
delivery errors of the Integral Quality Monitoring (IQM) device 
(iRT Systems GmbH, Koblenz, Germany), a system for online 
monitoring of Intensity Modulated Radiation Therapy (IMRT) 
treatments. To evaluate the correlation between the changes 
in the detector output signal induced by small delivery errors 
with other metrics, such as the γ passing rate and the DVH 
variations, which are commonly employed to quantify the 
deviations between calculated and actually delivered dose 
distributions. 
 
Material and Methods: IQM consists of a large area ionization 
chamber, with a gradient in the electrode plate separation, 
to be mounted on the treatment head, and a calculation 
algorithm to predict the signal based on the data received 
from the treatment planning system. The output of the 
ionization chamber provides a spatially dependent signal for 
each beam segment. 5 types of errors were induced in 
clinical IMRT step and shoot plans for head and neck (H&N), 
prostate and index quadrant planned with Pinnacle (Philips) 
with an Elekta Precise linac (6 MV), by modifying the number 
of delivered MUs and by introducing small deviations in leaf 
positions. The obtained dose distributions, both ‘error free’ 
(EF) and ‘error induced’ (EI) were delivered with the IQM 
system and the signal variations were recorded. EF and EI 
dose distributions were also compared in terms of: 1) 3D γ 
passing rate calculated on the entire dose volume; 2) 2D γ 
passing rate calculated on planar beam-by-beam dose 
distributions; 3) DVH metric, by calculating the differences 
for several significant DVH parameters. The correlation 
between IQM signal variations and 3D γ, 2D γ and DVH 
parameters was investigated. 
 
Results: IQM system resulted to be extremely sensitive in 
detecting small delivery errors. Variations in beam MU down 
to 1 are detected by the system as well as changes in field 
size and positions down to 1 mm. In Table 1 the variations in 
the IQM signal are reported as an example for an H&N plan.  
 
 
In Figure 1 the 2D γ per beam (1%/1mm, th10, local 
approach) and the PTV D95% and V95% are plotted vs the IQM 
signal variation for the same H&N example. A good 
correlation is observed thus suggesting that the IQM signal 
could be effectively used for quantifying delivery errors.  
 
 
 
Conclusion: IQM is capable of detecting small delivery errors 
in MU and leaves position and it shows a sufficient sensitivity 
for clinical practice. It also exhibits a good correlation with 
other metrics used to quantify the deviations between 
calculated and actually delivered dose distributions. Such 
